We narrowed to 7,531 results for: Ski;

1. pDONR223_SENP6_WT_V5

   Plasmid

   #83008

   Purpose

   Gateway Donor vector containing SENP6, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   SENP6 (SENP6 Human)
   

   Use

   Gateway entry vector

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. pDONR223_KRAS_p.G13C

   Plasmid

   #82809

   Purpose

   Gateway Donor vector containing KRAS, part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   KRAS (KRAS Human)
   

   Use

   Gateway entry vector

   Mutation

   G13C

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. pDONR223_ATF2_p.A481V

   Plasmid

   #82773

   Purpose

   Gateway Donor vector containing ATF2, part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   ATF2 (ATF2 Human)
   

   Use

   Gateway entry vector

   Mutation

   A481V

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

4. AAV-KrasG13V/sgKras/Cre

   Plasmid

   #99860

   Purpose

   Expresses Cre-recombinase, a barcoded HDR template to introduce a G13V mutation into the endogenous Kras locus, and a Kras-targeting sgRNA to enhance HDR.

   Depositor

   Monte Winslow

   Article

   Winters et al Nat Commun. 2017 Dec 12;8(1):2053. doi:

   Insert

   Kras (Kras Mouse)
   

   Use

   AAV and Cre/Lox

   Expression

   Mammalian

   Mutation

   AvrII site (CAAAGG>CCTAGG), PAM/sgRNA mutation…

   Available Since

   Dec. 13, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

5. pDONR223_GTF2A2_WT_V5

   Plasmid

   #82997

   Purpose

   Gateway Donor vector containing GTF2A2, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   GTF2A2 (GTF2A2 Human)
   

   Use

   Gateway entry vector

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. pDONR223_KRAS_p.G12Y

   Plasmid

   #82799

   Purpose

   Gateway Donor vector containing KRAS , part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   KRAS (KRAS Human)
   

   Use

   Gateway entry vector

   Mutation

   G12Y

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. pDONR223_RB1_p.Y756C

   Plasmid

   #82863

   Purpose

   Gateway Donor vector containing RB1, part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   RB1 (RB1 Human)
   

   Use

   Gateway entry vector

   Mutation

   Y756C

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. pDONR223_BRAF_p.L485S

   Plasmid

   #82837

   Purpose

   Gateway Donor vector containing BRAF, part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   BRAF (BRAF Human)
   

   Use

   Gateway entry vector

   Mutation

   L485S

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

9. pDONR223_BRAF_p.A762E

   Plasmid

   #82823

   Purpose

   Gateway Donor vector containing BRAF, part of the Target Accelerator Plasmid Collection.

   Depositor

   Matthew Meyerson, Jesse Boehm, David Root

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   BRAF (BRAF Human)
   

   Use

   Gateway entry vector

   Mutation

   A762E

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. pDONR223_BRAF_p.H574Q

    Plasmid

    #82825

    Purpose

    Gateway Donor vector containing BRAF, part of the Target Accelerator Plasmid Collection.

    Depositor

    Matthew Meyerson, Jesse Boehm, David Root

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    BRAF (BRAF Human)
    

    Use

    Gateway entry vector

    Mutation

    H574Q

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. pDONR223_BRAF_p.H574N

    Plasmid

    #82813

    Purpose

    Gateway Donor vector containing BRAF , part of the Target Accelerator Plasmid Collection.

    Depositor

    Matthew Meyerson, Jesse Boehm, David Root

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    BRAF (BRAF Human)
    

    Use

    Gateway entry vector

    Mutation

    H574N

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. pDONR223_BRAF_p.L613F

    Plasmid

    #82822

    Purpose

    Gateway Donor vector containing BRAF, part of the Target Accelerator Plasmid Collection.

    Depositor

    Matthew Meyerson, Jesse Boehm, David Root

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    BRAF (BRAF Human)
    

    Use

    Gateway entry vector

    Mutation

    L613F

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. pDONR223_BRAF_p.R682W

    Plasmid

    #82810

    Purpose

    Gateway Donor vector containing BRAF, part of the Target Accelerator Plasmid Collection.

    Depositor

    Matthew Meyerson, Jesse Boehm, David Root

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    BRAF (BRAF Human)
    

    Use

    Gateway entry vector

    Mutation

    R682W

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

14. pBABEpuro-ERBB2 C315S

    Plasmid

    #40986

    Depositor

    Matthew Meyerson

    Article

    Greulich et al Proc Natl Acad Sci U S A. 2012 Sep 4;109

    Insert

    ERBB2 (ERBB2 Human)
    

    Use

    Retroviral

    Expression

    Mammalian

    Mutation

    C315S

    Available Since

    Nov. 6, 2012

    Availability

    Academic Institutions and Nonprofits only

15. pBABEpuro-ERBB2 C338S

    Plasmid

    #40987

    Depositor

    Matthew Meyerson

    Article

    Greulich et al Proc Natl Acad Sci U S A. 2012 Sep 4;109

    Insert

    ERBB2 (ERBB2 Human)
    

    Use

    Retroviral

    Expression

    Mammalian

    Mutation

    C338S

    Available Since

    Nov. 6, 2012

    Availability

    Academic Institutions and Nonprofits only

16. pBABEpuro-ERBB2 C331S

    Plasmid

    #40989

    Depositor

    Matthew Meyerson

    Article

    Greulich et al Proc Natl Acad Sci U S A. 2012 Sep 4;109

    Insert

    ERBB2 (ERBB2 Human)
    

    Use

    Retroviral

    Expression

    Mammalian

    Mutation

    C331S

    Available Since

    Nov. 6, 2012

    Availability

    Academic Institutions and Nonprofits only

17. pDMJ2-SARS-CoV-2-Spike (BA.5-2e)

    Plasmid

    #241102

    Purpose

    Expresses SARS-CoV-2 spike (BA.5-2e) protein for creating pseudotyped virus

    Depositor

    Jeremy Luban

    Article

    Youssef et al Immunity. 2025 May 6:S1074-7613(25)00178

    Insert

    Spike (BA.5-2e) (S SARS-CoV-2)
    

    Expression

    Mammalian

    Mutation

    Q493R,T76I,T19I,L24del,P25del,P26del,A27S,H69del,…

    Available Since

    Oct. 16, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

18. pDMJ2-SARS-CoV-2-Spike (BA.1)

    Plasmid

    #241055

    Purpose

    Expresses SARS-CoV-2 spike (BA.1) protein for creating pseudotyped virus

    Depositor

    Jeremy Luban

    Article

    Youssef et al Immunity. 2025 May 6:S1074-7613(25)00178

    Insert

    Spike (BA.1) (S SARS-CoV-2)
    

    Expression

    Mammalian

    Mutation

    A67V,H69del,V70del,T95I,G142D,V143del,Y144del,Y14…

    Available Since

    Oct. 16, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

19. pDMJ2-SARS-CoV-2-Spike (CH.1.1)

    Plasmid

    #241112

    Purpose

    Expresses SARS-CoV-2 spike (CH.1.1) protein for creating pseudotyped virus

    Depositor

    Jeremy Luban

    Article

    Youssef et al Immunity. 2025 May 6:S1074-7613(25)00178

    Insert

    Spike (CH.1.1) (S SARS-CoV-2)
    

    Expression

    Mammalian

    Mutation

    T19I,L24del,P25del,P26del,A27S,G142D,K147E,W152R,…

    Available Since

    Oct. 2, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

20. pDMJ2-SARS-CoV-2-Spike (XBB-3a)

    Plasmid

    #241123

    Purpose

    Expresses SARS-CoV-2 spike (XBB-3a) protein for creating pseudotyped virus

    Depositor

    Jeremy Luban

    Article

    Youssef et al Immunity. 2025 May 6:S1074-7613(25)00178

    Insert

    Spike (XBB-3a) (S SARS-CoV-2)
    

    Expression

    Mammalian

    Mutation

    T19I,L24del,P25del,P26del,A27S,V83A,G142D,Y144del…

    Available Since

    Sept. 16, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge